A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout
A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout...
Brief Summary
Official Title: “A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout”
A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
- Study Primary Completion Date: May 2005
Intervention(s) in this Clinical Trial
- Drug: MK0663; etoricoxib / Duration of Treatment: 5 Days
- Drug: Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days
Outcome Measures for this Clinical Trial
Primary Measures
- Patient assessment of pain (0- to 4- Likert scale)
Secondary Measures
- Patient Global Assessment of Response to Therapy (0- to 4- point scale)
- Investigator Global Assessment of Response to Therapy (0- to 4- point scale)
- Tenderness of the study joint (0- to 3-point scale)
- Swelling of the study joint (0- to 3-point scale)
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Males or females at least 18 years of age who have acute gout.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Merck Industry
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Merck
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00142558
Study ID Number: 2005_062
ClinicalTrials.gov Identifier: NCT00142558
Health Authority: China: State Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00142558
